Contact

• workRoom 5048 Division of Medical Sciences and Graduate Entry Medicine
  Royal Derby Hospital
  Uttoxeter Road
  Derby
  DE22 3DT
  UK
• Daniela.ViramontesHorner2@nottingham.ac.uk

Biography

I graduated with honours from the BSc Nutrition and Dietetics, University of Guadalajara, Mexico in 2009. I worked for 3 years (2011-2014) for a Mexican company specialising in kidney disease in the innovation, research and development department working on randomised controlled clinical trials related with the effect of symbiotics on gastrointestinal symptoms, nutritional status, inflammation and kidney function in people with chronic kidney disease not on dialysis, as well as in people receiving haemodialysis. I graduated with distinction from the MRes Dietetics, University of Nottingham in 2015. I finished my PhD in the Centre for Kidney Research and Innovation, University of Nottingham in 2019. Currently, I am a research fellow (level 4) working in the Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham.

Expertise Summary

• Skin autofluorescence, a marker of tissue advanced glycation end-product accumulation, in people receiving dialysis and in kidney transplant recipients.
• Pre-, pro- and symbiotics in people with chronic kidney disease and in those receiving dialysis.
• Immuno-nutrition in people receiving haemodialysis.

Research Summary

Immuno-nutrition to improve "muscle health" in people receiving haemodialysis. iTrend (Intelligent Technologies for Renal Dialysis) project. The primary goal of this programme is to develop… read more

Current Research

• Immuno-nutrition to improve "muscle health" in people receiving haemodialysis.
• iTrend (Intelligent Technologies for Renal Dialysis) project. The primary goal of this programme is to develop supporting technologies and real-time analysis of data to enable personalised and precision treatment for people receiving haemodialysis. The ability to continuously monitor blood pressure both in terms of absolute measures and blood pressure variability could lead to new diagnostic and prognostic criteria for intradialytic hypotension, as well as optimal and personalised treatment strategies.

Past Research

Effect of symbiotics on gastrointestinal symptoms, nutritional status, inflammation and kidney function in persons with chronic kidney disease and end-stage kidney disease on haemodialysis.

Future Research

• Nutritional interventions to decrease skin autofluorescence, a marker of systemic inflammation and oxidative stress, in people receiving dialysis and kidney transplant recipients.
• Impact of pre-, pro- and symbiotics on nutritional status, markers of systemic inflammation and oxidative stress, and clinical/patient-centred outcomes in non-dialysed chronic kidney disease and dialysis populations.
• Nutritional and exercise interventions to prevent and/or treat malnutrition/protein-energy wasting in dialysis populations.